Comparative Analysis of Aging-appropriate Information in Chinese and American drug Instruction for the Treatment of Chronic Diseases in the Elderly
10.3870/j.issn.1004-0781.2024.12.010
- VernacularTitle:老年慢性病治疗药物中美药品说明书适老化信息对比分析
- Author:
Boya ZHOU
1
;
Zhigang ZHAO
;
Hao LU
;
Mingfen WU
;
Xixi LI
;
Shu GE
;
Huiyan MA
;
Shuancheng FAN
Author Information
1. 首都医科大学附属北京妇产医院/北京妇幼保健院药事部,北京 100006
- Keywords:
Drug instruction;
Aging;
Therapeutic drugs;
Chronic diseases;
Readability
- From:
Herald of Medicine
2024;43(12):1936-1943
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the differences in aging-related information between Chinese and American drug instruction for common chronic disease in the elderly,and to propose policy recommendations for the aging-related drug instruction in China.Methods Ten common chronic disease treatment drugs for elderly patients were selected,and through the random sampling method,the drug manuals of one domestic manufacturer were randomly selected for each drug by the random number method,and one American drug manual was selected as a sample from the dailymed website,and the information related to elderly people in the various items of the drug manuals was statistically analyzed by using Excel for comparative analysis.The average reading level of the patient version of the U.S.drug instructions was calculated using the Readability Formulas Scoring System;the readability of the Chinese drug instructions was assessed by the Health Education Text Material Suitability Scale.Results Compared with the U.S.drug instruction,the drug instruction for common chronic diseases of the elderly in China were updated less frequently and at a slower pace;the drug instruction with information on medication for elderly patients were fewer than those of the U.S.drug instruction,and the content of the drug instruction was not well documented;and the drug instruction were poorly readable,which was not conducive to the comprehension of the elderly patients.Conclusion China is in urgent need of reforming the aging of drug instructions,and it is recommended that,for chronic disease medications for elderly patients,we should increase the number of clinical trials conducted on the elderly,improve and complete the drug information for the elderly in the drug instructions,and produce"drug instructions for elderly patients"that are suitable for the elderly to read and understand.
